Category: Finance
-
Early-Stage Life Science Investment Fund Raises $515M
A new venture investment fund raised $515 million for life science start-ups, and its business incubator partner added five biotechs to its seed round portfolio.
-
Synthetic Bio Company Goes Public in $2.5B Merger
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.
-
Infographic – Public Money Funds Covid-19 Vaccines
As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project is starting to emerge.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.
-
Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-
Biomanufacturing Materials Company Issues $500M IPO
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering.
-
Microbiome Health Company Raises $40M in Early Funds
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round.
-
Small Biz Award Funds Home Elder Muscle Device
A start-up company spun-off from Dartmouth College received a grant to develop a device for older people to measure their muscle mass exercises at home.
-
Concrete Mfring Processes Win CO2 Conversion Challenge
Two companies with alternative techniques for manufacturing concrete won a challenge competition to convert carbon dioxide into useful products.